Bio-Techne FY26 net earnings more than doubled to $240.68 million; net sales slip 0.38% to $1.22 billionPUBT·15 hours agoTECH+0.21%MKKGY+0.37%
TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its ShareholdersMorningStar·Aug 22 at 03:52 AMTECH+0.21%MKKGY+0.37%
Werewolf Therapeutics sells preclinical INDUCER, INDUKINE platforms to EMD Serono for USD 33 millionPUBT·Aug 20 at 03:07 PMHOWL+1.12%MKKGY+0.37%
BlackRock lifts Merck stake to 8.22% as shares rise, instruments fallPUBT·Aug 20 at 02:22 AMMKKGY+0.37%MRK
Germany's Merck KGaA Raises Outlook on Robust Results, Easing Currency HeadwindsMorningStar·Aug 6 at 12:31 AMMKKGY+0.37%MRK
MRK: Solid group margins and modest growth, with Life Science and Healthcare outperforming ElectronicsQuartr·Aug 6 at 12:12 AMMRK
MRK: Upgraded 2026 guidance follows robust Q2 growth in Life Science and ElectronicsQuartr·Aug 6 at 12:12 AMMKKGY+0.37%TECH+0.21%
Merck KGaA Q2 EBITDA pre rises 9.4% to € 1.6 billion; net sales increase 3.4% to € 5.43 billionPUBT·Aug 6 at 12:10 AMMKKGY+0.37%MRK
